Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Other (1)
• Plasma (single spun) (2)
• Saliva (1)
• Serum (4)
• Stool (2)
• Urine (first morning) (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (1)
• Not applicable (4)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (4)

Associated Data

• Biomarker datasets (1)
• Clinical records (3)
• Followup records (4)
• Freezer temperature logs (3)
• Genomic datasets (1)
• Microbiological results (1)
• Participant Ethnicity (3)
• Pre-analytical data (1)
• Quality indicators (1)
• Survey data (2)
• Treatment records (5)

Timeframe

• Immediate (2)
• 0 - 3 months (5)
• 3 - 6 months (2)
• > 6 months (3)

Participant Count

• 11 - 100 (3)
• 101 - 500 (3)

Sex

• Male (1)
• Female (1)
• Both sexes (4)

Age Range

• Adolescent (12 - 18 years) (5)

Biobank Services

• Ability to recontact (1)
• Cell culture (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (2)

Collection Type

• Clinical Trial (1)
• Cohort (1)
• Cross-sectional (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (5)
• No Export restriction (4)
• No Genetic analysis restriction (3)
• No Human genetic analysis restriction (3)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (4)

Collection Status

• Completed (3)
• In progress (2)
• Not-started (1)

Access Condition

• Open to applicants (2)
• Open only through collaboration (2)
• Data access only (1)

Country

• Belgium (1)
• Peru (2)
• Switzerland (1)
• Uganda (1)
• United States (1)

County